Legal & General Group
PAVM icon

Legal & General Group’s PAVmed PAVM Stock Holding History

Legal & General Group’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13
Closed -$5K – 3478
2022
Q2 		$5K Sell
13
-4
-24% -$1.93K ﹤0.01% 3445
2022
Q1 		$10K Hold
17
– – ﹤0.01% 3404
2021
Q4 		$18K Hold
17
– – ﹤0.01% 3310
2021
Q3 		$64K Hold
17
– – ﹤0.01% 2924
2021
Q2 		$49K Buy
17
+2
+13% +$4.72K ﹤0.01% 2955
2021
Q1 		$30K Buy
15
+5
+50% +$7.52K ﹤0.01% 2988
2020
Q4 		$9K Hold
10
– – ﹤0.01% 3373
2020
Q3 		$8K Sell
10
-3
-23% -$2.67K ﹤0.01% 3309
2020
Q2 		$12K Buy
+13
New +$13K ﹤0.01% 3265

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Legal & General Group's PAVM Position: Q3 2022 in Review

Legal & General Group sold out of PAVmed (PAVM) in Q3 2022, closing a stake of 13 shares — an estimated $5K sold.

Legal & General Group first reported a position in PAVM in Q2 2020 and held it in 9 quarters. The position peaked at $64K in Q3 2021. 70 funds tracked by Wall St. Rank hold PAVM as of Q3 2022.

  • Legal & General Group reported no remaining PAVmed position as of Q3 2022 after selling out during the quarter.
  • Legal & General Group sold 13 PAVmed shares in Q3 2022, an estimated $5K.
  • Legal & General Group first reported a position in PAVmed in Q2 2020 and held it in 9 quarters.
  • Legal & General Group's PAVmed position peaked at $64K in Q3 2021.
  • 70 funds tracked by Wall St. Rank held PAVmed as of Q3 2022.

Based on Legal & General Group's 13F filing for Q3 2022, filed 14 Nov 2022.